Also called Mohs micrographic surgery
Used to treat skin cancer, this surgery has a unique benefit. During surgery, the surgeon can see where the cancer stops. This isn’t possible with other types of treatment for skin cancer.
The ability to see where the cancer stops gives Mohs (pronounced Moes) two important advantages:
If you have Mohs surgery, you’ll see a doctor who is a trained Mohs surgeon. Most Mohs surgeons are dermatologists who have completed extensive training in Mohs surgery.
During Mohs surgery, most patients remain awake and alert. This means Mohs can safely be performed in a medical office or surgical suite. Only if extensive surgery is necessary would you be admitted to a hospital.
On the day of the surgery, your surgeon will first examine the area to be treated. You’ll then be prepped for surgery. This includes giving you an injection of anesthetic. This injection only numbs the area that will be operated on, so you’ll be awake during the surgery.
Once the anesthetic takes effect, the surgery can begin. The surgeon starts by first cutting out the visible skin cancer. Next, the surgeon removes a thin layer of surrounding skin. You’re then bandaged so that you can wait comfortably.
While you wait, the Mohs surgeon looks at the removed skin under a microscope. The surgeon is looking for cancer cells. If cancer cells are found, you’ll need another layer of skin removed.
Some wounds heal without stitches.
A: The Mohs surgeon didn’t stitch the wound on this man’s lip. B: 6 weeks later, the wound has healed on its own.
This process of removing a thin layer of skin and looking at it under a microscope continues until the surgeon no longer sees cancer cells.
Once cancer cells are no longer seen, your surgeon will decide whether to treat your wound. Some wounds heal nicely without stitches. Others need stitches. To minimize the scar and help the area heal, some patients require a skin graft or other type of surgery.
If you need wound treatment, your Mohs surgeon may treat the wound that same day. Some patients with a large wound are referred to another surgeon for wound treatment.
Most Mohs patients have a common type of skin cancer like basal cell carcinoma (BCC) or squamous cell carcinoma (SCC). Mohs is usually recommended when a BCC or SCC:
Mohs is also used to treat some rare skin cancers like DFSP, extramammary Paget’s disease, and Merkel cell carcinoma.
Yes, dermatologists occasionally recommend Mohs for treating melanoma, the most serious type of skin cancer. Mohs is only used to treat an early melanoma, and it must be a type of melanoma called lentigo malignant melanoma. This type of melanoma stays close to the surface of the skin for a while.
When treating melanoma, the surgeon uses a modified type of Mohs surgery called slow Mohs. It’s called slow because the patient must wait longer for the results. It’s not possible for the surgeon to look at the removed skin and know right away whether it contains cancer cells. More time is needed.
If you have slow Mohs, the surgeon will remove the visible skin cancer and a bit of normal-looking skin around it. You’ll then be bandaged and sent home.
Most patients return the next day. It’s then that the patient learns whether more skin must be removed or the wound can be closed. Again, some wounds are left to heal on their own.
No matter what type of skin cancer you have, Mohs is only recommended for certain patients. You must have one skin cancer or a few skin cancers that are very close together.
Having any type of surgery can be scary. If your dermatologist recommends Mohs, you can take comfort in knowing a few facts. Mohs has a high cure rate. Your surgeon will remove the least amount of skin needed to treat the cancer.
Image used with permission of Journal of the American Academy of Dermatology: J Am Acad Dermatol. 2007; 57:832-5.
References
Nouri K, Patel AR, et al. “Mohs micrographic surgery.” In: Nouri K. Skin Cancer. The McGraw-Hill Companies, Inc., China, 2008:482-490.
Schaeffer M, Geisler A, et al. “Patient-reported preferences associated with Mohs micrographic surgery of nonmelanoma skin cancer: Relative importance of factors pertaining to surgeons and staff during the perioperative course.” Poster presented at: 74th Annual Meeting of the American Academy of Dermatology; 2016 Mar 4-8; Washington, DC. Commercial support: None identified.
Stigall LE, Brodland DG, et al. “The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.” J Am Acad Dermatol. 2016 Nov;75(5):1015-121.
Walker E, Mann M, et al. “Rapid visualization of nonmelanoma skin cancer.” J Am Acad Dermatol. 2017 Feb;76(2):209-16.
